Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: study protocol

BACKGROUND: Definitive radiation therapy (dRT) is an effective initial treatment of intermediate-risk (IR) and high-risk (HR) prostate cancer (PCa). PSMA PET/CT is superior to standard of care imaging (CT, MRI, bone scan) for detecting regional and distant metastatic PCa. PSMA PET/CT thus has the po...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Calais, Jeremie, Zhu, Shaojun, Hirmas, Nader, Eiber, Matthias, Hadaschik, Boris, Stuschke, Martin, Herrmann, Ken, Czernin, Johannes, Kishan, Amar U., Nickols, Nicholas G., Elashoff, David, Fendler, Wolfgang P.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8103642/
https://ncbi.nlm.nih.gov/pubmed/33962579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-021-08026-w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados